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AbstrAct
Objectives To determine the accuracy of 
predictions of dying at different cut-off 
thresholds and to acknowledge the extent of 
clinical uncertainty.
Design Secondary analysis of data from a 
prospective cohort study.
setting An online prognostic test, accessible by 
eligible participants across the UK.
Participants Eligible participants were 
members of the Association of Palliative 
Medicine. 99/166 completed the test (60%), 
resulting in 1980 estimates (99 participants × 
20 summaries).
Main outcome measures The probability of 
death occurring within 72 hours (0% certain 
survival−100% certain death) for 20 patient 
summaries. The estimates were analysed using 
five different thresholds: 50/50%, 40/60%, 
30/70%, 20/80% and 10/90%, with percentage 
values between these extremes being regarded 
as ‘indeterminate’. The positive predictive value 
(PPV), negative predictive value (NPV) and the 
number of indeterminate cases were calculated 
for each cut-off.
results Using a <50% versus >50% threshold 
produced a PPV of 62%, an NPV of 74% and 
5% indeterminate cases. When the threshold 
was changed to ≤10% vs ≥90%, the PPV and 
NPV increased to 75% and 88%, respectively, 
at the expense of an increase of indeterminate 
cases up to 62%.
conclusion When doctors assign a very high 
(≥90%) or very low (≤10%) probability of 
imminent death, their prognostic accuracy is 
improved; however, this increases the number 
of ‘indeterminate’ cases. This suggests that 
clinical predictions may continue to have a 
role for routine prognostication but that other 
approaches (such as the use of prognostic scores) 
may be required for those cases where doctors’ 
estimates are indeterminate.
IntrODuctIOn
Palliative care doctors are frequently 
asked to make predictions about the future 
health outcomes for their patients; this is 
what they base treatment decisions on. 
One such prediction is about whether a 
patient is imminently dying. This has been 
shown to be a difficult task.1–3 Towards 
the end of life, accurate recognition of the 
dying phase can enable a ‘good death’ to 
occur, with the patient’s final wishes being 
achieved, surrounded by loved ones and 
harmful interventions ceased.4–6 These 
wishes cannot be fulfilled if the clinical 
team are not able to recognise accurately 
that the person is dying. Although clini-
cian predictions of survival are frequently 
inaccurate and overoptimistic,7–9 they 
are still quite well correlated with actual 
survival and so are still recommended for 
use in routine clinical practice.10
The ‘More Care: Less Pathway’ report 
into the limitations of the Liverpool Care 
Pathway (LCP) described, among other 
things, the dissatisfaction of relatives with 
the information they were given about 
how long their relative was expected 
to live. A particular issue arose when 
patients, who were not in fact immi-
nently dying, were cared for using the 
LCP. The report included a recommenda-
tion that more research was needed into 
the best way to communicate prognostic 
uncertainty. A recent report from the 
Royal College of General Practitioners 
highlighted how difficult doctors find it 
to initiate a discussion about dying with 
people who have a terminal disease.11 
The report describes many barriers to this 
discussion including the fact that some 
doctors feel unconformable discussing 
uncertainty. For these reasons, it is vital 
to improve doctors’ ability to recognise 
when patients are imminently dying in 
order to initiate conversations about 
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prognosis, including the appropriate communication 
of uncertainty.
There is a lack of evidence on the final days of life 
on which to base clinical practice1 2 and little is under-
stood about how doctors recognise dying.12 Further-
more, it has been recognised that uncertainty might 
be an inherent part of predicting dying.13 14 For these 
reasons, we wanted to examine how certain a doctor 
needs to be that a death is likely to be imminent in 
order to have the highest diagnostic accuracy.
In a previously reported study, we asked palliative 
care doctors across the UK to participate in an online 
prognostic task.3 The task presented 20 patient summa-
ries of real patients who had been referred to specialist 
palliative care, of whom half died within 72 hours and 
half survived beyond 72 hours. As part of this task, the 
doctors were asked to read the summaries and provide 
a probability estimate of that patient dying within the 
next 72 hours.
For the purpose of this paper, we analysed the results 
of the prognostic task to explore the following:
1. Do palliative care doctors use the full range of probabili-
ty estimates from 0% (certain survival) to 100% (certain 
death) when asked if a patient is imminently dying?
2. What is the effect on prediction accuracy of using differ-
ent probability thresholds to predict which patients will 
or will not die imminently.
MethODs
study design
This is a secondary analysis of data collected as part 
of a prospective study to investigate how palliative 
care doctors recognise imminently dying patients.3 
This paper follows Standards for Reporting Diagnostic 
accuracy studies (STARD) reporting guidelines (see 
online supplementary file 1).
Participants
All medical doctors who were members of the Asso-
ciation of Palliative Medicine (APM) were invited to 
participate. Recruitment took place between 22 April 
2016 and 1 July 2016.
Patient and public involvement
Members of the South West London Cancer Research 
Network, consisting of patients and bereaved rela-
tives, reviewed the study documentation for the wider 
prospective observational study.3
Procedure
An email was distributed via the association secre-
tariat to all APM members containing a web link to an 
online prognostic test. Consent was sought via a tick 
box prior to participation. Participants were asked to 
provide some demographic information about them-
selves before completing the study.
The prognostic test contained 20 patient summaries, 
presented as ‘vignettes’. Each summary was about a 
patient who had been referred to specialist palliative 
care services, in either a hospice or hospital setting. 
In addition to a narrative summary of the patient’s 
condition, supplementary information was presented: 
blood test results, medications and observations such 
as temperature or oxygen saturation level (where avail-
able). All patients were monitored to record if death 
occurred within 72 hours so that this actual outcome 
could be compared with the doctors’ probability esti-
mates. An example of a patient summary can be seen in 
online supplementary file 2 to show the level of detail 
presented.
Participants were asked to read through each patient 
summary and provide an estimated percentage prob-
ability (any number between 0% and 100%) that the 
patient would die within the next 72 hours.
test methods
The prognostic test of interest was the percentage esti-
mate of the likelihood of death in the next 72 hours 
provided by the participants. Previous literature has 
suggested that 50% is an estimate often used in place 
of ‘I don’t know’.15 Therefore, we started by assuming 
that every prediction about the probability of immi-
nent death made by a clinician indicated either that 
the patient was likely to die (if the estimate was greater 
than 50%) or that the patient was likely to survive (if 
the estimate was less than 50%). Estimates of exactly 
50% were regarded as being ‘indeterminate’.
Then, we investigated the effect of classifying 
patients with scores in between two more extreme 
values as having an ‘indeterminate’ prognosis. For 
instance, we investigated how the accuracy of predic-
tions would be affected if only estimates of imminent 
death of ≥60% were taken to indicate that a patient 
would be likely to die; an estimate of imminent death 
of ≤40% indicated that a patient would be likely to 
survive; and an estimate between 41% and 59% was 
regarded as being ‘indeterminate’. This process was 
repeated for different threshold values. Thus, we also 
looked at using threshold values of ≤30%, 31%–69% 
and ≥70%; values of ≤20%, 21%–79% and ≥80%; 
and finally at values of ≤10%, 11%–89% and ≥90%. 
In total, we looked at five different ways of grouping 
the clinicians’ survival probabilities. The 30%/70% 
cut-off range has previously been suggested as the 
most clinically meaningful grouping.16 17
Analysis
The demographics of the respondents and of the 
patients described in the vignettes were summarised 
using mean (SD) and number (%). For each of the 
20 patient vignettes, the clinicians’ predictions of the 
probability of imminent death were summarised across 
all participating clinicians using median and IQR. The 
clinicians’ predictions were then compared with the 
known patient survival outcomes. The accuracy of 
their predictions under these different threshold values 
was summarised in a series of 2×2 tables, showing 
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Figure 1 Study flow diagram.
Table 1 Demographics of participants
Demographic N=99
Gender (n, %)
  Male 21 (21)
  Female 78 (79)
  Age (mean, SD) 41 (9.5)
Ethnicity (n, %)
  White British 87 (88)
  Other 12 (12)
Years since qualified (mean, SD) 17 (10.3)
Years in specialist palliative care (mean, SD) 12 (8.4)
true positives, false positives, true negatives and false 
negatives (where ‘positive’=death within 72 hours, 
and ‘negative’=survived 72 hours). The indeterminate 
predictions were omitted from this analysis. The posi-
tive predictive value (the proportion of patients who 
died when the clinician predicted dying) and the nega-
tive predictive value (the proportion of patients who 
survived when the clinician predicted survival) were 
calculated.
results
A total of 166 participants started the test, of 
whom 99 (60%) provided survival probabilities for 
all 20 case histories. Data from participants who 
did not complete all of the cases were excluded 
from the analysis because they were judged to have 
lost interest in the task and/or not treated it suffi-
ciently seriously. The majority of non-completers 
(41/67) stopped the test after reading the first case 
history. All but two other participants completed 
less than half of the assessments. Thus, there were 
1980 estimates provided by the participants (99 
doctors each provided 20 estimates) included in the 
analysis. Figure 1 shows the flow of participants in 
the study, and the number of predictions of death/
survival within 72 hours according to each of the 
five threshold value groupings. In this figure, ‘posi-
tive’ refers to the number of estimates predicting 
death within 72 hours, and ‘negative’ refers to the 
number of estimates predicting survival. Table 1 
shows the demographics of respondents. Table 2 
presents a brief demographic background of the  o
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Table 2 Characteristics of the patients presented within the 
prognostic test
Demographics n (%)
Total number of participants 20
Gender
  Male 13 (65)
  Female 7 (35)
  Age (mean, SD) 71.45 (18.88)
Ethnicity
  White British 13 (65)
  Other 7 (35)
Cancer diagnosis?
  Yes 14 (70)
  No 6 (30)
Charlson score (mean, SD) 5.00 (1.89)
Length of survival
  Within 72 hours 10 (50)
  Outside 72 hours 10 (50)
Figure 2 Boxplot of responses to each vignette.
patients presented to the participants within the 
case summaries.
use of percentage probability estimates
Figure 2 shows the median and IQR of the probability 
estimates given by the 99 respondents for each of the 
20 vignettes included in the prognostic test. This does 
not represent the order in which they were presented 
to the participants. Vignettes 1–10 are those where 
the patient died within 72 hours. Vignettes 11–20 are 
those where the patient survived for over 72 hours. 
For 6 patients, the median predicted probability of 
dying was between 90% and 100%, 2 patients had a 
median estimate between 0% and 20% of dying and 
12 patients had a median estimate between 20% and 
80%
Participants used the full range of the scale 
(0%–100%) in their survival predictions. There was 
one vignette in which the median response by the 
participants was greater than 90% probability of dying 
and the patient survived beyond 72 hours.
 o
n
 28 M
ay 2019 by guest. Protected by copyright.
http://spcare.bmj.com/
BM
J Support Palliat Care: first published as 10.1136/bmjspcare-2018-001761 on 10 May 2019. Downloaded from 
5White N, et al. BMJ Supportive & Palliative Care 2019;0:1–7. doi:10.1136/bmjspcare-2018-001761
Research
Table 3 Accuracy of clinician probability estimates using different double thresholds (including indeterminate values)
Estimate cut-off Prediction*
Outcome (within 72 hours)
Outcomes Proportion of indeterminate 
cases 
Died Survived Total
N PPV NPV
>50% Die 787 478 1265 62%
<50% Survive 163 456 619 74%
50%–50% Indeterminate 40 56 96 5%
≥60% Die 766 446 1212 63%
≤40% Survive 144 422 566 75%
41%–59% Indeterminate 80 122 202 10%
≥70% Die 685 356 1041 66%
≤30% Survive 87 338 425 80%
31%–69% Indeterminate 218 296 514 26%
≥80% Die 577 247 824 70%
≤20% Survive 39 256 295 87%
21%–79% Indeterminate 374 487 861 43%
≥90% Die 440 149 589 75%
≤10% Survive 19 141 160 88%
11%–89% Indeterminate 531 700 1231 62%
*Each estimate was categorised in to a group if the estimate was above or below the cut-off. Scores that were indeterminate were omitted from the 
analysis. PPV (positive predictive value; the proportion of patients who died when the clinician predicted dying, eg, 787/1265 for the 50% cut-off), NPV 
(negative predictive value; the proportion of patients who survived when the clinician predicted survival, eg, 456/619 for the 50% cut-off).
the assessment of accuracy
Table 3 shows the accuracy of clinicians’ predictions 
about the probability of imminent death at each of the 
five thresholds. The resulting number of ‘indetermi-
nate’ scores is also presented. The positive predictive 
value of the clinical prediction (ie, the proportion of 
estimates of imminent death that correctly predicted 
that the patient would die imminently) improved from 
62% (at the 50% threshold) to 75% at the 10%/90% 
threshold. The negative predictive value of the clinical 
prediction (ie, the proportion of estimates of survival 
beyond 72 hours that correctly predicted the outcome) 
improved from 74% (at the 50% threshold) to 88% at 
the 10%/90% threshold.
Indeterminate cases
Applying the simplest threshold of <50% or >50%, 96 
estimates (5%) were ascribed a probability of exactly 
50% and were regarded as being indeterminate. The 
number of indeterminate cases increased steadily with 
each change in the thresholds applied until at the ≤10 
%/≥90% threshold, 1231 estimates were deemed to 
be indeterminate (1231/1980; 62% of all estimates). 
In these 1231 indeterminate estimates, 700 (57%) 
patients survived and 531 (43%) died.
DIscussIOn
The principal finding from this study is that when 
using a <50% or >50% threshold, and ignoring 
predictions of exactly 50%, clinical predictions of 
imminent death are not very accurate (accuracy 66%). 
However, accuracy could be improved by adjusting 
the threshold values that are taken to indicate ‘likely 
death’ or ‘likely survival’. The best way to maximise 
accuracy was to only regard those predictions with a 
probability of ≥90% as indicating imminent death, 
and only those predictions with a probability of ≤10% 
as indicating likely survival beyond 72 hours, with 
all other values in between being regarded as ‘inde-
terminate’. The drawback with this strategy was that 
a relatively large proportion of clinician estimates 
would have been regarded as indeterminate. In our 
study 14/20 vignettes were ascribed a median prob-
ability estimate in the range between 10% and 90%, 
suggesting a majority of predictions would be regarded 
as uninformative using this approach.
It makes logical sense that the higher the probability 
estimate provided by the doctor, the more likely it is 
that the outcome will occur. However, these results 
illustrate how challenging it is to predict the immi-
nent future, even by specialist palliative care doctors. 
The results suggest it is important to acknowledge and 
discuss uncertainty whatever the level of the clini-
cian’s estimate, as is illustrated by one of the patient 
summaries used in the prognostic task. This patient 
survived for longer than 72 hours despite the median 
probability ascribed to his or her death being greater 
than 90%. Perhaps, however, clinical estimates in the 
range of 11%–89% should be regarded with greater 
circumspection.
Ultimately, the decision about which is the ‘best’ 
threshold to use is a qualitative and subjective one. 
What this analysis does is to quantitatively illustrate 
the effect of using different thresholds on the accu-
racy of clinicians’ predictions. Even when using the 
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highest threshold level (≥90%), clinicians’ predictions 
of imminent death were only correct on 75% of occa-
sions. Accuracy gradually increases for every rise in 
threshold value but at the extreme values the number 
of indeterminate cases escalates rapidly.
The European Association for Palliative Care (EAPC) 
has recommended that clinical predictions of survival 
should still hold an important role in prognostication, 
while accepting that, taken in isolation, clinical predic-
tions of survival are not very accurate.10 Other means 
to estimate prognosis in palliative care patients have 
been developed16 18–20 and are still being evaluated.21–23 
One question that therefore arises is when and how to 
combine clinical predictions of survival with prognostic 
scores, multidisciplinary team (MDT) decisions or 
algorithms. Our study suggests that clinical predictions 
of survival are at the most accurate when the thresholds 
of ≤10% and ≥90% are employed; however, there are 
important implications for the number of ‘indetermi-
nate’ estimates that arise as a result of this.
strengths and limitations
This is the first study to measure the accuracy of 
multiple doctors’ predictions about the imminent 
death of the same group of patients, thus allowing a 
direct comparison of their prognostic accuracy.
The prognostic test could be criticised for lacking 
some face validity as the doctors did not get to review 
the patients at a face-to-face assessment. Nonetheless, 
the vignettes all concerned real cases and included a 
detailed descriptive summary of the patient including 
routinely available blood results and other clinical find-
ings. A further limitation of this study is that the find-
ings are based on these specific 20 case histories, which 
may not be ‘representative’ of all the patients who will 
be observed in palliative care. Half of the vignettes in 
this sample died, and this might not be representative 
of survival times in palliative care. Further research 
is required to see if a different set of 20 summaries 
would produce similar results.
cOnclusIOn
Our results show that even when patients are very 
(>90%) confident that a patient will die within the 
next 72 hours, these estimates are only correct on 75% 
of occasions (and at the expense of a high number of 
indeterminate cases). It is therefore important for 
clinicians to convey this level of uncertainty in their 
communications with patients and relatives and not to 
forget that even their most confident predictions are 
inaccurate 25% of the time. This suggests that while 
clinical predictions will continue to have a role for 
routine prognostication, other approaches (such as the 
use of prognostic scores) may be required for those 
cases where doctors’ estimates are indeterminate.
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